Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome

Archives of Dermatology

Volumn 134, Issue 9, 1998, Pages 1108-1112

  Suzuki, Yosuke ^a   Inagi, Reiko ^b   Aono, Toshiya ^b   Yamanishi, Koichi ^b   Shiohara, Tetsuo ^a  

^a KYORIN UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG HYPERSENSITIVITY; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PRURITUS; RASH; VIRUS DETECTION; VIRUS REACTIVATION;

DNA, VIRAL; DRUG HYPERSENSITIVITY; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HUMANS; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYNDROME;

EID: 0031707391     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.9.1108     Document Type: Article

References (25)

1. Prussick P, Shear NH. Dapsone hypersensitivity syndrome. J Am Acad Dermatol. 1996;35:346-349.
2. Mok C-C, Lau C-S. Dapsone syndrome in cutaneous lupus erythematosus. J Rheumatol. 1996;23:766-768.
3. Chopra S, Levell NJ, Cowley G, Gilkes JJH. Systemic corticosteroids in the phenytoin hypersensitivity syndrome. Br J Dermatol. 1996;134:1109-1112.
4. Singer JZ, Wallace SL. The allopurinol hypersensitivity syndrome: unnecessary morbidity and mortality. Arthritis Rheum. 1986;29:82-87.
5. Arellano F, Sacristan J. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother. 1993;27:337-343.
6. MacNeil M, Haase DA, Tremaine R, Marrie TJ. Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline. J Am Acad Dermatol. 1997;36:347-350.
7. Rzany B, Mockenhaupt M, Stocker U, Hamouda O, Schöpf E. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany. Arch Dermatol. 1993;129:1059.
8. Pullen H, Wright N, Murdoch JM. Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis. Lancet. 1967;2:1176-1178.
9. Patel BM. Skin rash with infectious mononucleosis and ampicillin. Pediatrics. 1967;40:910-911.
10. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science. 1986;234:596-601.
11. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1988;1:1065-1067.
12. Levy JA, Ferro F, Greenspan D, Lenette ET. Frequent isolation of HHV-6 from saliva and high seroprevalence to the virus in the population. Lancet. 1990;335:1047-1050.
13. Knox KK, Carrigan D. Disseminated active HHV-6 infections in patients with AIDS. Lancet. 1994;343:577-578.
14. Yoshikawa T, Suga S, Asano Y, et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood. 1991;78:1381-1384.
15. Yoshikawa T, Kojima S, Asano Y. Human herpesvirus-6 infection and bone marrow transplantation. Leuk Lymphoma. 1992;8:65-73.
16. Tanaka-Taya K, Kondo T, Mukai T, et al. Seroepidemiological study of human herpesvirus-6 and -7 in children of different ages and detection of these two viruses in throat swabs by polymerase chain reaction. J Med Virol. 1996;48:88-94.
17. Akashi K, Eizuru Y, Sumiyoshi Y, et al. Severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 in an adult. N Engl J Med. 1993;329:168-171.
18. Appleton AL, Peiris JSM, Taylor CE, Sviland L, Cant AJ. Human herpesvirus 6 DNA in skin biopsy tissue from marrow graft recipients with severe combined immunodeficiency. Lancet. 1994;344:1361-1362.
19. Carrigan DR, Drobyski WR, Russler SK, Tapper MA, Knox KK, Ash RC. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet. 1991;338:147-149.
20. Chosidow O, Bourgault I, Roujeau J-C. Drug rashes: what are the targets of cell-mediated cytotoxicity? Arch Dermatol. 1994;130:627-629.
21. Nazareth IJ. Ampicillin and mononucleosis. BMJ. 1971;3:48.
22. Lunel F, Abuaf N, Frangeul L, et al. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology. 1992;16:630-636.
23. Manns MP, Obermayer-Straub P. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease. Hepatology. 1997;26:1054-1066.
24. Katsafanas GC, Schirmer EC, Wyatt LS, Frenkel N. In vitro activation of human herpesviruses 6 and 7 from latency. Proc Natl Acad Sci U S A. 1996;93:9788-9792.
25. Singh N, Carrigan DR. Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med. 1996;124:4065-4071.